Fuan Pharmaceutical (Group) Co Ltd Class A 300194
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥4.05
- Day Range
- ¥4.08–4.25
- 52-Week Range
- ¥2.92–5.15
- Bid/Ask
- ¥4.17 / ¥4.18
- Market Cap
- ¥4.97 Bil
- Volume/Avg
- 44.2 Mil / 19.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.41
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 1.23%
- Dividend Yield (Forward)
- 1.23%
- Total Yield
- 1.23%
Company Profile
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,292
- Website
- http://www.fapharm.com
Comparables
Valuation
|
Metric
|
300194
|
600594
|
002793
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.41 | — | — |
Price/Book Value | 1.12 | 0.99 | 1.87 |
Price/Sales | 1.84 | 1.08 | 1.84 |
Price/Cash Flow | 10.63 | 12.57 | — |
Price/Earnings
300194
600594
002793
Financial Strength
|
Metric
|
300194
|
600594
|
002793
|
|---|---|---|---|
Quick Ratio | 0.99 | 1.21 | 0.58 |
Current Ratio | 1.59 | 1.82 | 0.91 |
Interest Coverage | 12.64 | −3.36 | −8.58 |
Quick Ratio
300194
600594
002793
Profitability
|
Metric
|
300194
|
600594
|
002793
|
|---|---|---|---|
Return on Assets (Normalized) | 1.26% | −3.17% | −10.62% |
Return on Equity (Normalized) | 1.84% | −5.06% | −23.02% |
Return on Invested Capital (Normalized) | 1.44% | −3.17% | −11.96% |
Return on Assets
300194
600594
002793
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Gzkbfjhs | Scw | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Yxskxlbz | Cbcbjv | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Ntnbvvbf | Qybz | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Fqmcbrljc | Rhc | $19.0 Bil | |||
| Viatris Inc
VTRS
| Pgqmfyyy | Gxwwq | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qxrdkmr | Rwtr | $13.4 Bil | |||
| Catalent Inc
CTLT
| Rtxjzbq | Qqdzpd | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Yrzslzr | Thbjlyc | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Hzjnbrgc | Byn | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Hyzqtndsl | Wqt | $2.5 Bil |
United States